Clinical Trials Logo

Clinical Trial Summary

The rational of this study is to provide evidence on the safety and efficacy of a new chewable tablet of mebendazole compared to the standard tablet in preschool- and school-aged children infected with hookworm.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03995680
Study type Interventional
Source Swiss Tropical & Public Health Institute
Contact
Status Completed
Phase Phase 2
Start date July 12, 2019
Completion date October 9, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT03261596 - Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana Phase 4
Completed NCT05538767 - Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm Phase 2
Completed NCT03527745 - Albendazole Dose Finding and Pharmacokinetics in Children and Adults Phase 2
Active, not recruiting NCT06188715 - Efficacy and Safety of MOX/ALB Co-administration in SAC Phase 3
Active, not recruiting NCT04227834 - Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education N/A
Completed NCT04700423 - Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration Phase 2/Phase 3
Completed NCT03172975 - Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection Phase 2
Recruiting NCT06184399 - Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC Phase 2
Completed NCT04726969 - Efficacy and Safety of MOX/ALB Co-administration Phase 3
Completed NCT05017194 - Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm Phase 2
Completed NCT01163877 - Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma N/A